{"id":157369,"date":"2024-05-12T19:50:54","date_gmt":"2024-05-12T19:50:54","guid":{"rendered":"https:\/\/yogaesoteric.net\/?p=157369"},"modified":"2024-05-12T19:50:54","modified_gmt":"2024-05-12T19:50:54","slug":"two-possible-bird-flu-vaccines-could-be-available-within-weeks-if-needed","status":"publish","type":"post","link":"https:\/\/yogaesoteric.net\/en\/two-possible-bird-flu-vaccines-could-be-available-within-weeks-if-needed\/","title":{"rendered":"Two Possible Bird Flu Vaccines Could Be Available Within Weeks, if Needed"},"content":{"rendered":"

NBC News<\/em> reported:<\/p>\n

The U.S. has two vaccines ready should the strain of bird flu circulating in dairy cows begin spreading easily to people, federal health officials said. They could begin shipping doses widely within weeks, if needed.<\/p>\n

\"\"<\/p>\n

So far, there\u2019s no evidence that H5N1 is spreading person-to-person, although one dairy worker in Texas who worked closely with infected cattle had a mild infection and developed conjunctivitis, or pinkeye, in April.<\/p>\n

At a recent briefing, government health officials said they are preparing for a potential scenario of H5N1 jumping from animal to person \u2014 or person to person. The virus has taken off in dairy cows, infecting at least 36 herds across nine states, raising concerns that it could acquire mutations that would make it easier to spill over into humans.<\/p>\n

Both of the vaccine candidates are already in the nation\u2019s stockpile in limited quantities, officials said in a previous interview.<\/p>\n

The Centers for Disease Control and Prevention also said that it is testing blood samples from people previously vaccinated with an influenza vaccine to see if it generates an immune response, although it didn\u2019t say which vaccine.<\/p>\n

Thousands Believe Covid Vaccines Harmed Them. Is Anyone Listening?<\/strong><\/p>\n

The New York Times<\/em> reported:<\/p>\n

Within minutes of getting the Johnson & Johnson covid vaccine, Michelle Zimmerman felt pain racing from her left arm up to her ear and down to her fingertips. Within days, she was unbearably sensitive to light and struggled to remember simple facts.<\/p>\n

She was 37, with a Ph.D. in neuroscience, and until then could ride her bicycle 20 miles, teach a dance class and give a lecture on advanced science, all on the same day. Now, more than three years later, she lives with her parents. Eventually diagnosed with brain damage, she cannot work, drive or even stand for long periods of time.<\/p>\n

Dr. Zimmerman\u2019s account is among the more harrowing, but thousands of Americans believe they suffered serious side effects following covid vaccination. As of April, just over 13,000 vaccine-injury compensation claims have been filed with the federal government \u2014 but to little avail. Only 19% have been reviewed. Only 47 of those were deemed eligible for compensation, and only 12 have been paid out, at an average of about $3,600.<\/p>\n

Some scientists fear that patients with real injuries are being denied help and believe that more needs to be done to clarify the possible risks. \u201cAt least long covid has been somewhat recognized<\/em>,\u201d said Akiko Iwasaki, an immunologist and vaccine expert at Yale University. But people who say they have post-vaccination injuries are \u201cjust completely ignored and dismissed and gaslighted<\/em>,\u201d she added.<\/p>\n

AstraZeneca \u2018Wriggling Off the Hook\u2019 as Some Families Drop Out of Legal Action Over Costs<\/strong><\/p>\n

The Telegraph<\/em> reported:<\/p>\n

Families whose loved ones died after taking the AstraZeneca covid vaccine have abandoned attempts to sue the pharmaceutical giant after being told that they were likely to lose.<\/p>\n

Gareth Eve and other families whose relatives were harmed after having the jab have pulled out of the High Court case after being told that they would be unlikely to succeed with their claims because a leaflet issued at the height of the pandemic warned of a rare side effect associated with the vaccine.<\/p>\n

The document, given out at vaccination centers, said that \u201cextremely rare cases of blood clots with low levels of platelets have been observed following vaccination with covid-19 vaccine AstraZeneca<\/em>.\u201d<\/p>\n

Legal experts believe that this could potentially protect the pharmaceutical firm against cases brought by families whose relatives were given a dose supplied after April 7, 2021. In total, 12 families have now dropped out of the legal action.<\/p>\n

More than 50 are still suing the pharmaceutical giant in the High Court, however, because their vaccines were supplied before the warning about blood clots was added to the patient safety leaflets.<\/p>\n

Moderna\u2019s Sales From Its Only Product, the Covid Vaccine, Fell 91% From Last Year<\/strong><\/p>\n

Fortune<\/em> reported:<\/p>\n

The dark days of the pandemic are finally in the past for most of us \u2014 and that seems to be reflected in the earnings for Moderna, whose revenue is dependent on sales of its covid-19 vaccine.<\/p>\n

In the first quarter of the year, Moderna reported $167 million in sales of its only product on the market, its covid vaccine called Spikevax<\/em>. The company\u2019s first-quarter revenue is down 91% from the $1.9 billion it reported in the same quarter last year.<\/p>\n

\"\"<\/p>\n

The plummeting revenue makes sense, considering the demand for the vaccine has been dropping since 2021, but it\u2019s not all bad news for the vaccine maker: Its revenue surpassed Wall Street\u2019s expectation of $97.5 million, and in turn, shares of Moderna jumped 7% recently.<\/p>\n

Near the end of April, the company also announced a new innovation to integrate AI and ChatGPT in its operations as part of an ongoing partnership with OpenAI since 2023, according to OpenAI\u2019s press release, and also has plans to roll out a new RSV vaccine this fall.<\/p>\n

GSK Knew About Zantac Cancer Risk, Attorneys Tell Jury in First Trial<\/strong><\/p>\n

Reuters<\/em> reported:<\/p>\n

U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac<\/em> recently told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.<\/p>\n

Mikal Watts, who is representing 89-year-old Angela Valadez, said the companies knew that Zantac<\/em>\u2019s active ingredient, ranitidine, would turn into a cancer-causing substance called NDMA as it aged or was exposed to extreme temperatures, but did not ensure it was properly handled by transporters, distributors and stores.<\/p>\n

Valadez\u2019s case is one of tens of thousands against GSK, Boehringer Ingelheim and other pharmaceutical companies, which have worried investors in recent years. It will offer the first test of whether the cancer claims in the long-running litigation will persuade a jury, since all cases previously set for trial settled or were dropped.<\/p>\n

GSK and Boehringer Ingelheim are the only defendants in the trial after other companies settled.<\/p>\n

University of Minnesota Strengthens Case to Treat Covid With Metformin, Not Ivermectin<\/strong><\/p>\n

StarTribune<\/em> reported:<\/p>\n

Patients with covid-19 had lower viral loads if treated with metformin, according to new University of Minnesota research that argues for broader use of the cheap anti-diabetes drug and against the controversial use of ivermectin.<\/p>\n

Recently published findings helped connect the dots and explain why metformin in a U-led clinical trial reduced the likelihood of covid-related hospitalizations or the development of long covid illness. The amount of virus in patients is often associated with the severity of illnesses and complications, and it was found to be almost fourfold lower in patients in the trial who took metformin vs. non-medicating placebo pills.<\/p>\n

The results \u201ccould be a tipping point<\/em>\u201d that convinces doctors to prescribe metformin to treat covid, said Dr. Carolyn Bramante, the lead U researcher of the drug trial. \u201cBut people are cautious about using repurposed meds<\/em>\u201d so she predicted many will wait for results of a larger federally funded drug trial called ACTIV-6<\/em>.<\/p>\n

The U study results also showed that metformin users were less likely to see a rebound in 10 days of their viral loads, which also can be a proxy for the development of post-covid complications, or long covid.<\/p>\n

Novo Nordisk Trims Price for Blockbuster Obesity Drug as Competition Heats Up<\/strong><\/p>\n

Reuters<\/em> reported:<\/p>\n

Novo Nordisk (NOVOb.CO) raised its 2024 outlook as the Danish drugmaker races to boost output of its Wegovy<\/em> weight-loss treatment, while competition from rival Eli Lilly forced the company to cut prices of the drug, knocking its shares.<\/p>\n

\"\"<\/p>\n

These are Novo\u2019s second set of results since Lilly launched the obesity drug Zepbound<\/em> in the United States in December and highlight the fast-changing dynamics as the two companies go head to head in a market that analysts estimate could be worth as much as $100 billion by the end of the decade.<\/p>\n

Prices for Wegovy<\/em> and diabetes treatment Ozempic<\/em>, which contains the same active ingredient, fell in the first quarter amid increased volumes and competition, the company\u2019s chief financial officer Karsten Munk Knudsen told analysts on a call.<\/p>\n

\u201cGiven increasing volume and competition, net pricing like-for-like will be down in the U.S<\/em>.\u201d, he said, adding that the trend would continue through the rest of the year.<\/p>\n

MRNA Vaccine Fights Deadly Brain Tumor in Small Trial<\/strong><\/p>\n

U.S. News & World Report<\/em> reported:<\/p>\n

An experimental cancer vaccine can quickly reprogram a person\u2019s immune system to attack glioblastoma, the most aggressive and lethal form of brain cancer, a small, preliminary study has found.<\/p>\n

The cancer vaccine is based on mRNA technology similar to that used in covid vaccines, but in this case, a patient\u2019s own tumor cells are used to create a personalized vaccine, researchers said. The vaccine teaches the immune system to see tumor cells as a dangerous virus, prompting a vigorous immune response against the cancer, researchers said.<\/p>\n

In a first-ever human clinical trial with four adult patients, the vaccine prompted a quick and apparently effective immune attack on cancer. The results mirror those seen in 10 pet dogs with brain tumors who served as early test subjects, as well as lab mice. Dogs offer a natural opportunity to test brain cancer therapies because they\u2019re the only other species that regularly develop brain tumors, the researchers explained.<\/p>\n

The vaccine now will be tested in a phase 1 pediatric clinical trial for brain cancer, researchers said.<\/p>\n

A New Form of Mpox That May Spread More Easily Found in Congo\u2019s Biggest Outbreak<\/strong><\/p>\n

Associated Press<\/em> reported:<\/p>\n

Congo is struggling to contain its biggest mpox outbreak, and scientists say a new form of the disease detected in a mining town might more easily spread among people.<\/p>\n

Since January, Congo has reported more than 4,500 suspected mpox cases and nearly 300 deaths, numbers that have roughly tripled from the same period last year, according to the World Health Organization. Congo recently declared the outbreak across the country a health emergency.<\/p>\n

An analysis of patients hospitalized between October and January in Kamituga, eastern Congo, suggests recent genetic mutations in mpox are the result of its continued transmission in humans; it\u2019s happening in a town where people have little contact with the wild animals thought to naturally carry the disease.<\/p>\n

Moderna Takes a \u2018Break\u2019 With New Virtual Communication Networks Series Spotlighting Scientists<\/strong><\/p>\n

Fierce Pharma<\/em> reported:<\/p>\n

Moderna has launched a new video series to energize its virtual communication networks followers\u2019 midafternoon breaks.<\/p>\n

Each instalment in the \u201cCoffee Break Science<\/em>\u201d series will include an interview with one of Moderna\u2019s scientists, who will \u201cunpack a fascinating topic related to viruses, vaccines, or immunology<\/em>\u201d while grabbing a coffee, the pharma said in the caption of its first episode.<\/p>\n

Moderna isn\u2019t alone in kick-starting a campaign that highlights its scientists and has them explain their work in a relaxed setting. GSK previously launched its own \u201cScience on the Sofa<\/em>\u201d series, in which the company\u2019s experts were tapped to take a load off and chat about GSK\u2019s work in treating various diseases.<\/p>\n

Meanwhile, both AbbVie and Pfizer have recently put out corporate branding blasts focused on each company\u2019s goal of making scientific breakthroughs \u2014 including AbbVie\u2019s \u201cThe Case for Big Bets<\/em>\u201d campaign and Pfizer\u2019s \u201cHere\u2019s to Science<\/em>\u201d ad, the latter of which aired at this year\u2019s Super Bowl.<\/p>\n

 <\/p>\n

yogaesoteric
\nMay 12, 2024<\/strong><\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

NBC News reported: The U.S. has two vaccines ready should the strain of bird flu circulating in dairy cows begin spreading easily to people, federal health officials said. They could begin shipping doses widely within weeks, if needed. So far, there\u2019s no evidence that H5N1 is spreading person-to-person, although one dairy worker in Texas who […]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[1102],"tags":[],"class_list":["post-157369","post","type-post","status-publish","format-standard","hentry","category-risks-for-your-health-4260-en-health-en"],"_links":{"self":[{"href":"https:\/\/yogaesoteric.net\/en\/wp-json\/wp\/v2\/posts\/157369","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/yogaesoteric.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/yogaesoteric.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/yogaesoteric.net\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/yogaesoteric.net\/en\/wp-json\/wp\/v2\/comments?post=157369"}],"version-history":[{"count":1,"href":"https:\/\/yogaesoteric.net\/en\/wp-json\/wp\/v2\/posts\/157369\/revisions"}],"predecessor-version":[{"id":157379,"href":"https:\/\/yogaesoteric.net\/en\/wp-json\/wp\/v2\/posts\/157369\/revisions\/157379"}],"wp:attachment":[{"href":"https:\/\/yogaesoteric.net\/en\/wp-json\/wp\/v2\/media?parent=157369"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/yogaesoteric.net\/en\/wp-json\/wp\/v2\/categories?post=157369"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/yogaesoteric.net\/en\/wp-json\/wp\/v2\/tags?post=157369"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}